Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Weydt

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|September 27, 2005
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survivalPatrick Weydt, Soyon Hong, Anke Witting, et al.
Journal of Neurochemistry|June 11, 2004
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic miceAnke Witting, Patrick Weydt, Soyon Hong, et al.
The American Journal of Hospice & Palliative Care|April 2, 2004
Survey of cannabis use in patients with amyotrophic lateral sclerosisDagmar Amtmann, Patrick Weydt, Kurt L Johnson, et al.
Neurology. Genetics|July 12, 2021
Effect of Body Weight on Age at Onset in Huntington Disease: A Mendelian Randomization StudyJorien M M van der Burg, Patrick Weydt, Georg Bernhard Landwehrmeyer, et al.
Plos One|December 27, 2014
Prodromal Huntington disease as a model for functional compensation of early neurodegenerationKathrin Malejko, Patrick Weydt, Sigurd D Süßmuth, et al.
Idrugs : the Investigational Drugs Journal|June 6, 2003
Drug therapy for amyotrophic lateral sclerosis: Where are we now?Gregory T Carter, Lisa S Krivickas, Patrick Weydt, et al.
Annals of Neurology|October 24, 2025
Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral SclerosisPaula Lindenborn, Rachel Fabian, Torsten Grehl, et al.
Brain Communications|January 7, 2022
Teaching an old dog new tricks: serum troponin T as a biomarker in amyotrophic lateral sclerosisSergio Castro-Gomez, Barbara Radermacher, Pawel Tacik, et al.
Acta Neuropathologica|November 9, 2019
Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosisPatrick Oeckl, Patrick Weydt, Dietmar R Thal, et al.
Journal of Molecular Neuroscience : MN|November 18, 2015
Clinical Trials in Spinal and Bulbar Muscular Atrophy-Past, Present, and FuturePatrick Weydt, Anna Sagnelli, Angela Rosenbohm, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|September 27, 2005
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survivalPatrick Weydt, Soyon Hong, Anke Witting, et al.
Journal of Neurochemistry|June 11, 2004
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic miceAnke Witting, Patrick Weydt, Soyon Hong, et al.
The American Journal of Hospice & Palliative Care|April 2, 2004
Survey of cannabis use in patients with amyotrophic lateral sclerosisDagmar Amtmann, Patrick Weydt, Kurt L Johnson, et al.
Neurology. Genetics|July 12, 2021
Effect of Body Weight on Age at Onset in Huntington Disease: A Mendelian Randomization StudyJorien M M van der Burg, Patrick Weydt, Georg Bernhard Landwehrmeyer, et al.
Plos One|December 27, 2014
Prodromal Huntington disease as a model for functional compensation of early neurodegenerationKathrin Malejko, Patrick Weydt, Sigurd D Süßmuth, et al.
Idrugs : the Investigational Drugs Journal|June 6, 2003
Drug therapy for amyotrophic lateral sclerosis: Where are we now?Gregory T Carter, Lisa S Krivickas, Patrick Weydt, et al.
Annals of Neurology|October 24, 2025
Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral SclerosisPaula Lindenborn, Rachel Fabian, Torsten Grehl, et al.
Brain Communications|January 7, 2022
Teaching an old dog new tricks: serum troponin T as a biomarker in amyotrophic lateral sclerosisSergio Castro-Gomez, Barbara Radermacher, Pawel Tacik, et al.
Acta Neuropathologica|November 9, 2019
Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosisPatrick Oeckl, Patrick Weydt, Dietmar R Thal, et al.
Journal of Molecular Neuroscience : MN|November 18, 2015
Clinical Trials in Spinal and Bulbar Muscular Atrophy-Past, Present, and FuturePatrick Weydt, Anna Sagnelli, Angela Rosenbohm, et al.
Pageof 11